Clinical Trial Update: PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting pharmacokinetics and ECG determinations after 8 weeks of HyBryte treatment in Cutaneous T-Cell Lymphoma/Mycosis Fungoides, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides

Drugs mentioned

• HyBryte (synthetic hypericin)

Snippet

Sponsor: Soligenix | Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides | Phase 2 | Status: COMPLETED | Results posted: 2023-06-07